Cancer Patient Perspectives During COVID-19

Completed

• Conditions: Breast Cancer

• Registration Number: NCT05062538
• Lead Sponsor: University of Colorado, Denver

Brief Summary

A web-based survey will be emailed to all adult women diagnosed with invasive breast cancer or ductal carcinoma in situ who have been seen as surgical consultations within the last year (06/01/19-06/01/20).

Detailed Description

A web-based survey will be emailed to all adult women diagnosed with invasive breast cancer or ductal carcinoma in situ who have been seen as surgical consultations within the last year (06/01/19-06/01/20). This will ensure that patients at various stages of treatment are included, from initial diagnosis into survivorship. This will allow the investigators to assess changes to initial consultations, surgeries, chemotherapy, and radiation, as well as patient perspectives as it relates to these changes.

The web-based surveys will be given via Redcap. The study team will use a validated questionnaire developed at the University of Miami (Penedo, 2020), which includes a combination of multiple-choice questions, Likert scale ratings, and yes/no questions. A list of potential questions is listed below.

A group of patients will be contacted for semi-structured interviews via telephone as well if (1) patients indicate willingness to participate on a separate RedCap survey or (2) if the patient does not respond to this survey. Phone interviews will be recorded and transcribed verbatim. Multiple members of the research team will separately code the information and evaluate for themes.

Study Timeline

• Study Start: 2020-08-24
• Primary Completion: 2021-02-20
• Study First Submitted: 2021-09-29
• Study First Submitted QC: 2021-09-29
• Study First Posted: 2021-09-30
• Status Verified: 2024-07
• Study Completion: 2024-07-15
• Last Update Submitted: 2024-07-25
• Last Update Posted: 2024-07-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 89

Inclusion Criteria

• Adult females with diagnosis of invasive breast cancer or ductal carcinoma in situ, seen as surgical consultation between 06/01/19-06/01/20

Read More

Exclusion Criteria

• Males
• Patients with non-cancer diagnoses
• Patients with no history of breast cancer

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of participants with changes implemented to breast cancer treatment	12 months	Number of participants with changes implemented to breast cancer treatment during the COVID-19 pandemic
Number of participants with treatment concerns during COVID-19 pandemic	12 months	Patients with treatment concerns during the COVID-19 pandemic
Number of participants with effects of COVID-19 on psychological, social, and physical well-being of breast cancer patients	12 months	Number of participants with effects of COVID-19 on psychological, social, and physical well-being of breast cancer patients

Trial Locations

Locations (1)

Colorado Research Center; 🇺🇸 Aurora, Colorado, United States